PI3K inhibitor X

CAS No. 956958-53-5

PI3K inhibitor X( XL-147 analog )

Catalog No. M16833 CAS No. 956958-53-5

PI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 Get Quote
5MG 45 Get Quote
10MG 72 Get Quote
25MG 128 Get Quote
50MG 205 Get Quote
100MG 354 Get Quote
200MG 460 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PI3K inhibitor X
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor.
  • Description
    PI3K inhibitor X (XL-147 analog) is a derivative of XL147 that acts as a reversible inhibitor of class I PI3Ks with IC50 of 39, 36, 23 and 383 nM for p110α, δ, γ and β respectively; Compound 147 in patent WO2012006552A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    XL-147 analog
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    DNA-PK|PI3Kα|PI3Kβ|PI3Kγ|PI3Kδ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    956958-53-5
  • Formula Weight
    448.5208
  • Molecular Formula
    C21H16N6O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=S(C1=CC=C(C)C=C1)(NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4)=O
  • Chemical Name
    Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Carlos L. Arteaga, et al. Combinations of kinase inhibitors for the treatment of cancer. WO 2012006552 A1.
molnova catalog
related products
  • Gynostemma Extract

    Gynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum.

  • ST-162

    ST-162 is a potent, bifunctional MAPK/PI3K antagonist with IC50 of 191 nM and 398 nM for PI3Kα and MEK1, respectively.

  • Duvelisib

    A potent, selective PI3Kδ/γ inhibitor with Ki of 23 pM/243 pM, IC50 of 1 nM/50 nM.